CSL Behring: Industry Analysis and Business Performance

This assignment requires a comprehensive analysis of CSL Behring, a global biotechnology company specializing in therapies for serious medical conditions. Students are tasked with examining the company's performance within the pharmaceutical-biotechnology industry, analyzing its competitive landscape, regulatory environment, and outlining key success factors contributing to its growth and profitability. The analysis should draw upon provided sources and research to provide a well-rounded understanding of CSL Behring's current position and future prospects.

Running head: SUISTAINABLE MANAGEMENT AND MARKETING
Sustainable Management and Marketing
Name of the Student
Name of the University
Author Notes

1
SUISTAINABLE MANAGEMENT AND MARKETING
Table of Contents
Introduction and Background of CSL Limited................................................................................2
Human Resource Management of CSL Limited.............................................................................7
Leadership in CSL...........................................................................................................................8
Control of Value Chain and Technology.........................................................................................9
Recommendations for Future Strategies........................................................................................10
Reference.......................................................................................................................................11

2
SUISTAINABLE MANAGEMENT AND MARKETING
Introduction and Background of CSL Limited
CSL Limited is an Australian based biotechnology company, which is specialized in the
manufacture of all types of biotechnological and advanced pharmaceutical products. Blood
plasma derivatives, vaccines, cell culture agents and immunogenic materials are few of the
important manufactured product line of the company. The company also manufacturers various
types of research kits that are used in investigation work of genetic and biotechnological work.
The company was initiated in the year 1916 under the brand name of Commonwealth
Serum Laboratories, which was initiated by the healthcare department in of Australia. At the
initial stage the company mainly focused on the manufacture of vaccines (Csl.com.au, 2017).
The board management of CSL Limited is responsible for oversight of the company and
providing strategic direction for Business Development. With effective leadership of the
company it is possible to properly assess the research and development section. The board of
CSL is operated by 10 members that is headed by the Chairman Professor John Shine and Paul
Perreault, who is the CEO and MD. Each department of the company is headed by a scientist or
professor, who are responsible the research and development program and the team of
researchers. The company has also employed marketing experts, who are responsible for the
implementing effective plan for the marketing. High standard of corporate governance is more
essential to deal with the promotion activities related to the company. Effective strategic
planning and risk management are major part of the company that helps to maintain
transparency. The board members of the company are responsible for providing future direction
that help them to develop biotechnological and Pharmaceutical products.

3
SUISTAINABLE MANAGEMENT AND MARKETING
In the 21st century, the progress of the Pharmaceutical department is entirely dependent
upon research work of biotechnological firms. As there is increase in the total number of chronic
diseases like high blood pressure, diabetes or deadly disease like cancer, there is an increase
demand in the market for advanced modern medicine. The principles of biotechnology are being
applied in the manufacturing process of modern medicine, which are effective in providing gene
therapy for permanent cure of deadly diseases. The biotechnological industry is dependent upon
application of biological principles and techniques, in a manufacturing process of advanced level
of medicine. It is essential to have a high level of technological infrastructure for global
development of biotechnology industry. There are nearly 200 new therapies and modern
medicines that are introduced with the help of biotechnology research (Danzonand andKeuffel
2014). These new medicines have created new business opportunity for the biotechnology and
Pharmaceutical firms in the Global market. The excellent research facilities that are available
with the department of Australia along with some world class scientists, it is possible to
introduce some of the latest forms of medicine. Some of the key areas of success in
biotechnology industry of Australia is due to their advanced level of clinical trials. Currently
there are more than 500 biotechnology companies operating under the pharmaceutical industry of
Australia (Wilsonet al. 2014).
It is important for the CSL limited to conduct proper business environment, which is
done with the help of elements of political, social, economic and legal factors.
The political stability in the biotechnology and pharmaceutical industry of Australia
plays a major part in the business development of CSL. There is also the risk of high level of
corruption that are involved in the political environment of biotechnology industry.

4
SUISTAINABLE MANAGEMENT AND MARKETING
It is also important for the company to consider the economic condition of Australia. The
government intervention in the free market of Pharmaceutical and Biotechnology industry is a
significant part in economic growth of the company (PopescuandPopescu 2015).
The society of Australia, which is highly focused upon getting latest form of modern
medicine also, has a major impact on the business performance of CSL. The competitive
environment of the biotechnology industry in Australia can be determined with the help of the
technological infrastructure. As more number of companies are entering into the biotechnology
industry, it is essential to consider about the Technological infrastructure of the rivals, which can
cause major competitive disadvantage for CSL (Jacksonet al. 2017).
The Government of Australia has also implemented strict legal protocol for
pharmaceutical manufacturers. These include discrimination law and intellectual property law,
which will ensure that there is no illegal manufacture of any forms of modern medicine that are
developed with the help of biotechnological principles (Limited, 2017).
The company is of high important in context of the biotech industry of Australia. CSL
has the highest market share in their respective domain and all over the globe the company plays
a crucial part in the advancement of the modern medicine using the principles of Biotech. The
company is also important in context of the future research work. This is due to the fact it has the
potential to introduce new forms of therapies for all deadly dieses and also improve over the
existing distribution system of all types of pharmaceutical products.
Planning of CSL Limited
The important mission and vision of CSL Limited is to be passionate about providing
quality and safe products to the customer, which is obtained from high level of extensive

5
SUISTAINABLE MANAGEMENT AND MARKETING
research. The commitment level towards the client of the company is provided with the help of
five main core values, which help in maintaining sustainability in the business environment.
Patient focus
Being repeated Global Biotech Company; one of the major aim of CSL is to focus up on
the needs of patient suffering from Life threatening diseases. The company focuses upon the
challenges that are encountered by people in various health challenging situations. The research
and development team of CSL is aiming to introduce new therapies, which can improve the
existing clinical treatment procedures of life threatening diseases. The company also aims to
maintain sustainability by reducing the accessibility of advanced medicine for all group of
patient (Cslbehring.com, 2017).
Innovation
Implementation of innovation in biotech and Pharmaceutical research work is one of the
basic organisational missions of CSL. The company has invested use capital in improving upon
the technological infrastructure that includes introduction of robust pipeline for better safety and
effectiveness of the lifesaving medicine. The innovative ideas are possible due to the talented
scientists that are recruited by CSL. The goal of the company to have the ability to maintain
sustainability can be fulfilled with its ability to make effective future decisions related to the
research work of biotechnology. The innovative ideas are also effective in the process of
decision making process (Cslbehring.com, 2017). The innovative ideas are also implemented on
the basis of improving the marketing ideas related to better marketing strategies.
Integrity

6
SUISTAINABLE MANAGEMENT AND MARKETING
With the help of integrity which is also one of the major aims of the company, it is
possible for the company management to communicate properly with the people of community
and stakeholders. With the help of proper communication it is possible to maintain transparency
within the work and manufacturing process of Pharmaceutical products. As the company is able
to establish high level of trust, it is possible for them to maintain long term relationship with the
community and stakeholder groups.
Collaboration
The company works in collaboration with various scientific communities that is highly
essential in improving the research and development section. The company has also
implemented special human resource policy to employee bio technological experts from different
cultural backgrounds, which helps to improve the organisational strength of maintaining
diversity. The company has also developed partnership with various Healthcare communities,
Biopharmaceutical Company and Clinical Research Centre, which help them to deliver better
health care service. As the company is able to form partnership with all major Nations, it is
possible for them to expand upon their business. With the exchange of scientific ideas related to
development of modern medicine it can help in the process of better development of advanced
research work in designing modern medicine. With the help of collaboration work it is also
possible for the company to have the ability to sustain and biotechnological industry.
Superior Performance

7
SUISTAINABLE MANAGEMENT AND MARKETING
Superior results are provided by the company in the manufacturing process of
Pharmaceutical products, it can help them to develop upon their reputation and provide valuable
service to the society. The Pursuit for excellence is one of the major aims of the company, which
is the central idea for success and sustainable development in business. The main aim of the
company is to constantly improving upon their organisational skills that are necessary in
maintaining sustainability of the workplace(Eldridge and Eldridge, 2017).
Proper clinical trials are done before every set of drugs all Pharmaceutical products are
released in a market. The environment health safety and sustainability are the few of the major
elements of commitment that are provided by the company. The company has also implemented
strong commitment towards matter related to environment conservation. It is also essential to
avoid the environmental hazards that are associated with research work of biotechnology. Proper
safety protocols are being followed in the research Labs that is meant to ensure high level of
workplace safety.
Human Resource Management of CSL Limited
Being one of the largest biotechnological industrial firms, the CSL limited has its
facilities in all the major Nations including Australia, Germany, United Kingdom, Switzerland
and United States. Currently the company is having more than 17000 employees, who are
recruited from 30 Nations all across the globe. It is important to mention in this context that
effective human resource policy is essential to improve over the organisational reputation and
performance (Cslbehring.com, 2017). The executive management of CSL limited has
implemented effective human resource policy, which is aim to improve the overall business

8
SUISTAINABLE MANAGEMENT AND MARKETING
policy and research and development work. The Global employee relations that are established
by the human resource manager operate in a wide range of models.
Research and development team of CSL consists of 27% of the total employees.
Compared to other Biotech companies CSL limited has more scientific research experts, which
has helped them to introduce new therapies and Pharmaceutical products (Cslbehring.com,
2017). This policy of the company to recruit more scientist and Biotech experts can have the
company to sustain better due to the fact that there will be great demand of improving the
modern medicine to deal with major life threatening challenges. Research and development team
of the company also gets opportunity to work with diverse group of experts, which help them to
improve over their practical knowledge skill and social communication skill. This is highly
essential in improving the network chain of the company, thereby improving over their brand
popularity.
The diversity in the workforce that is maintained by CSL is believed to be Highly
Effective in dealing with long term success plan of the company (Cslbehring.com, 2017). The
human resource policy of the company is reflected upon within the cultural diversity that is
maintained within the workplace of the company.
Leadership in CSL
As mentioned in the previous section, one of the major important elements of CSL that
has helped them to improve their level of performance is due to the fact that they have been able
to provide better leadership skills. The company mainly follows the Global style of leadership,
which is headed by the CEO Paul Perrault. The main focus of the company leaders and manager
is to focus upon the future sustainability of Biotech and Pharmaceutical research work.

9
SUISTAINABLE MANAGEMENT AND MARKETING
The leadership style which encourages cultural diversity and effective workforce
communication has been a major cause of success of the company over past several years. The
management of the company also encourages innovative research work, which motivates
Research and Development group to take up the risk of implementing new method in modern
medicine design (Verbekeet al. 2016).
In spite of the major planning work one of the major issues that has not been encounter
by CSL is due to the fact that the company has not been able deal with the ethical issues. This
has compromised upon the quality of research work that has been done by the research and
development team. In many of the cases, the result of the research work could not be validated.
This is mainly in the cases of dealing with the test result of the newly introduced drugs before
they are being released in the market (de la Cueva-Méndez and Seliktar 2015).
Control of Value Chain and Technology
The board members of CSL Limited are responsible in controlling all the major activities
related to operation management. Both the CEO and chairman of the company have
implemented effective communication skills with the stakeholders, which has helped the
company to improve over their supply chain network about the Global community of Biotech
and Pharmaceutical research work (Cslbehring.com, 2017).
As the company has increased the workforce over the past several years, the range of
supply chain and operation management also has improved. This has also helped the company to
improve over their share hold in the Global market of biotechnology and Pharmaceutical
products. The last financial year, the company has been able to invest 25 million dollars in

10
SUISTAINABLE MANAGEMENT AND MARKETING
introducing new research firms and medical facilities that can be used for improving the drug
testing ability (Cslbehring.com, 2017).
The company has implemented strict policy and vigilance survey deal with effective
supplier management chain. In the department of manufacturing, the operation team has
successfully been able to outsource critical resources, which is possible due to strict monitoring
of supplier's risk profile. The major activities of supply chain operation include dealing with
alternative suppliers, procurement of the resource to ensure safety of the available stock. The
company has also maintained rigorous relationship with the entire supply chain network, which
is believed to be one of the important elements of corporate social responsibility. The vast chain
of supplier network that has been built by the company over past several years is essential in
maintaining sustainability of the business and reputation of the company.
Future Strategies
Sustainability of the company is the basis of all future strategies implemented by CSL.
Following are few of the effective future strategies of the company:
 Investment in valuable portfolio helps in the development of company’s future products.
This has also been a major weak point of the company as they has not been able to invest
more in the past. The future strategy will aim to recover from this weak point and
increase the revenue investment amount.
 The company has faced ethical challenges in the past while conducting advanced level of
genetic research work. The future strategies need to focus upon implementing strict

11
SUISTAINABLE MANAGEMENT AND MARKETING
action to deal follow the ethical codes by getting approval for all forms of research work
from the scientific society (Csl.com.au. 2017). In order to improve upon the human
resource strategy, the company is aiming to maintain high level of transparency with all
categories of employees
.
 From the previous analysis it is clear that CSL has effective leadership quality and to
maintain the same in future, it is essential for them to recruit more number of
biotechnologist within the company that will help to improve the decision making
capability (Danzon and Keuffel 2014). This will also help the company to gain
competitive advantage, which is highly challenging in the context of the present
scenario.
Recommendations
Based on the analysis and details of the company that is mentioned in the previous sections
there are few recommendations that are provided, which will aim to provide better workforce
sustainability and development work of research:
 It is important to focus upon the development of future research work, which is primarily
essential for development of medical fields (Kilbane 2017).

12
SUISTAINABLE MANAGEMENT AND MARKETING
 There should be internal training program that needs to incorporate for the research and
development team that will aim to provide latest information. This can be possible by
providing detail access of the database related to biotechnological research work
(Crommelinet al. 2013).
 It is important for the company to access the risk of the future risks of the company.
 One of the major weaknesses that exist in CSL is relevantto the few of the ethical issues
that the company has violated in conducting the work or genetics. It is therefore
recommended by the company to take proper ethical consents from the healthcare
research department.

13
SUISTAINABLE MANAGEMENT AND MARKETING
Reference
Crommelin, D.J., Sindelar, R.D. and Meibohm, B. eds., 2013. Pharmaceutical biotechnology:
fundamentals and applications. Springer Science & Business Media.
Csl.com.au. (2017). CSL Ltd is a leader in plasma protein biotherapeutics. [online] Available at:
http://www.csl.com.au/about [Accessed 12 Oct. 2017].
Csl.com.au. (2017). CSL's investment in research and development. [online] Available at:
http://www.csl.com.au/research-development/investments.htm [Accessed 13 Oct. 2017].
Cslbehring.com. (2017). CSL Behring Global Leadership. [online] Available at:
http://www.cslbehring.com/about/management-team.htm [Accessed 12 Oct. 2017].
Cslbehring.com. (2017). CSL Behring: About Us, Vision & Values, Commitment to Best Quality
Therapies. [online] Available at: http://www.cslbehring.com/about/csl-behring-vision-values.htm
[Accessed 12 Oct. 2017].
Danzon, P.M. and Keuffel, E.L., 2014. Regulation of the pharmaceutical-biotechnology industry.
In Economic Regulation and Its Reform: What Have We Learned? (pp. 407-484). University of
Chicago Press.
Danzon, P.M. and Keuffel, E.L., 2014. Regulation of the pharmaceutical-biotechnology industry.
In Economic Regulation and Its Reform: What Have We Learned? (pp. 407-484). University of
Chicago Press.
de la Cueva-Méndez, G., and Seliktar, D. 2015. Editorial overview: Pharmaceutical
biotechnology: Expanding horizons for pharmaceutical biotechnology in industry and academia.

14
SUISTAINABLE MANAGEMENT AND MARKETING
Eldridge, E. and Eldridge, E. (2017). Can CSL Limited’s (ASX:CSL) ROE Continue To Surpass
The Industry Average?. [online] Simply Wall St. Available at:
https://simplywall.st/news/2017/09/29/can-csl-limiteds-asxcsl-roe-continue-to-surpass-the-
industry-average/ [Accessed 13 Oct. 2017].
Jackson, J.K., Hussainy, S.Y. and Kirkpatrick, C.M., 2017. Identification of major factors in
Australian primary care pharmacists’ practice environment that have a bearing on the
implementation of professional models of practice. Australian Health Review, 41(4), pp.378-383.
Kilbane, J.J., 2017. II (2016) Future applications of biotechnology to the energy industry.
Petroleum Microbial Biotechnology: Challenges and Prospects, p.9.
Limited, C. (2017). CSL Limited: Private Company Information - Bloomberg. [online]
Bloomberg.com. Available at:
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=881503 [Accessed
13 Oct. 2017].
Popescu, C.R. and Popescu, V.A., 2015. Phases and Actions of the Evolution of the Concept of
Quality in Canda and Australia-A Theoritical Modelling of the Development of Knowledge in
Business Perfromance in the XXI Century-The Approach to Excellence. Manager, (21), p.18.
Verbeke, W., Bagozzi, R.P. and Belschak, F.D., 2016. The role of status and leadership style in
sales contests: A natural field experiment. Journal of Business Research, 69(10), pp.4112-4120.
Wilson, G.A., Perepelkin, J., Di Zhang, D. and Vachon, M.A., 2014. Market orientation, alliance
orientation, and business performance in the biotechnology industry. Journal of Commercial
Biotechnology, 20(2).

15
SUISTAINABLE MANAGEMENT AND MARKETING